# Ivabradine

## Coralan 5mg

| TAH Drug Code      | [OCOR5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCOR5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Chronic heart failure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | Initial， 5 mg orally twice daily with food; after 2 weeks， adjust based on heart rate; for resting rate greater than 60 beats per minute (bpm)， increase dose by 2.5 mg twice daily; for 50 to 60 bpm， continue current dose; for less than 50 bpm or for signs or symptoms of bradycardia， decrease dose by 2.5 mg twice daily; Maximum dose: 7.5 mg twice daily.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | 1.Hypersensitivity to the active ingredients or any excipients of this medicine. 2. Before treatment， resting heart rate is less than 70 bpm. 3. Psychogenic shock. 4. Acute myocardial infarction. 5. Severe hypotension (<90/50mmHg). 6. Severe liver insufficiency. 7. Sick sinus syndrome. 8. Sino-atrial block. 9. Unstable or acute heart failure. 10. Those who use a heart rate regulator (the heartbeat is completely controlled by the heart rate regulator). 11. Unstable angina sufferers. 12. Patients with 3rd degree atrioventricular block (AV-block). 13. Use in combination with strong inhibitors of cytochrome p450 3A4， such as azole antifungal agents (ketoconazole， itraconazole)， macrolide antibiotics (clarithromycin， oral erythromycin， josamycin， telithromycin)， HIV protease inhibitors (nelfinavir， ritonavir) and nefazodone. 14. Used in combination with verapamil or diltiazem， this preparation is a moderate inhibitor of cytochrome p450 3A4 with heart-lowering properties. 15. Pregnant women， lactating women， and women of childbearing age who do not use appropriate contraceptive measures. |
| Adverse Effects    | Cardiovascular: Bradycardia (6% to 10%)， hypertension (9%)， atrial fibrillation (5% to 8%)， heart block， sinoatrial arrest Central nervous system: Phosphene (3%) <1% (Limited to important or life-threatening): Angioedema， diplopia， erythema， hypotension， pruritus， skin rash， syncope， urticaria， vertigo， visual impairment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/ivabradine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

